David Bankeroff

SLS Program Committee Chair & Head of US Sales, Alcon Laboratories

David Bankeroff has 33 years of experience in the Consumer Products industry and his career has spanned top CPG companies across a variety of functions including Sales, Market Strategy, Supply chain and Customer Service. Dave started his CPG career in 1992 with The Gillette Company and transitioned to Procter & Gamble in 2006 after the acquisition. Dave started his focus in the OTC space when he joined Novartis OTC in 2010 and then transitioned to Alcon in 2013 where he has held his current position as Head of OTC Sales for the past 8 years. In his current role Dave has managed several innovative product launches including the successful Rx-to-OTC switch of Pataday in 2020. Dave is passionate about eyecare and Alcon’s mission to help people see brilliantly. Dave has served as board member at CHPA since 2021.

Dave has a Business degree from a University of Missouri Columbia, a Master of Science in Healthcare Administration from Nova Southeaster and an MBA from University of North Carolina, Chapel Hill.